These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 3318751)
1. Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial. Lederle FA; Pluhar RE; Joseph AM; Niewoehner DE Arch Intern Med; 1987 Dec; 147(12):2201-3. PubMed ID: 3318751 [TBL] [Abstract][Full Text] [Related]
2. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715 [TBL] [Abstract][Full Text] [Related]
4. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study. Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878 [TBL] [Abstract][Full Text] [Related]
5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
6. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis. Busse WW; Massanari M; Kianifard F; Geba GP Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616 [TBL] [Abstract][Full Text] [Related]
7. Observational study of intravenous versus oral corticosteroids for acute asthma: an example of confounding by severity. Clark S; Costantino T; Rudnitsky G; Camargo CA Acad Emerg Med; 2005 May; 12(5):439-45. PubMed ID: 15860696 [TBL] [Abstract][Full Text] [Related]
8. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245 [TBL] [Abstract][Full Text] [Related]
9. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. Mullarkey MF; Blumenstein BA; Andrade WP; Bailey GA; Olason I; Wetzel CE N Engl J Med; 1988 Mar; 318(10):603-7. PubMed ID: 3278232 [TBL] [Abstract][Full Text] [Related]
11. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
12. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL; J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679 [TBL] [Abstract][Full Text] [Related]
13. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease? Vondracek SF; Hemstreet BA Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512 [TBL] [Abstract][Full Text] [Related]
14. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S; Vogelmeier C; Buhl R Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroid-induced myopathy mimicking therapy-resistant asthma. Yamaguchi M; Niimi A; Minakuchi M; Matsumoto H; Shimizu K; Chin K; Mishima M Ann Allergy Asthma Immunol; 2007 Oct; 99(4):371-4. PubMed ID: 17941287 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal of inhaled corticosteroid under cover of nedocromil sodium. Paananen M; Karakorpi T; Kreus KE Eur J Respir Dis Suppl; 1986; 147():330-5. PubMed ID: 3021500 [TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209 [TBL] [Abstract][Full Text] [Related]
18. [Glucocorticoids in asthmatic crisis in children]. Bidat E; Scheinmann P Arch Fr Pediatr; 1990 Apr; 47(4):291-6. PubMed ID: 2194442 [TBL] [Abstract][Full Text] [Related]
19. The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid-dependent asthmatics. Bakran I; Korsić M; Duraković Z; Vrhovac B; Tajić M Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):57-60. PubMed ID: 328415 [TBL] [Abstract][Full Text] [Related]
20. Effects of N-acetylcysteine on asthma exacerbation. Aliyali M; Poorhasan Amiri A; Sharifpoor A; Zalli F Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):103-9. PubMed ID: 20683104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]